Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Video observations of treatment administration to children on antiretroviral therapy in rural KwaZulu-Natal.

Coetzee B, Kagee A, Bland R.

AIDS Care. 2016 Mar;28 Suppl 2:34-41. doi: 10.1080/09540121.2016.1176674.

2.

Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.

Ouattara EN, Robine M, Eholié SP, MacLean RL, Moh R, Losina E, Gabillard D, Paltiel AD, Danel C, Walensky RP, Anglaret X, Freedberg KA.

Clin Infect Dis. 2016 Jun 1;62(11):1454-62. doi: 10.1093/cid/ciw117. Epub 2016 Mar 1.

PMID:
26936666
3.

Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.

Wilhelmson S, Reepalu A, Balcha TT, Jarso G, Björkman P.

Glob Health Action. 2016 Jan 12;9:29943. doi: 10.3402/gha.v9.29943. eCollection 2016.

4.

High prevalence of PI resistance in patients failing second-line ART in Vietnam.

Thao VP, Quang VM, Day JN, Chinh NT, Shikuma CM, Farrar J, Van Vinh Chau N, Thwaites GE, Dunstan SJ, Le T.

J Antimicrob Chemother. 2016 Mar;71(3):762-74. doi: 10.1093/jac/dkv385. Epub 2015 Dec 11.

5.

Outcome of patients on second line antiretroviral therapy under programmatic condition in India.

Chakravarty J, Sundar S, Chourasia A, Singh PN, Kurle S, Tripathy SP, Chaturbhuj DN, Rai M, Agarwal AK, Mishra RN, Paranjape RS.

BMC Infect Dis. 2015 Nov 14;15:517. doi: 10.1186/s12879-015-1270-8.

6.

Second-Line HIV Therapy Outcomes and Determinants of Mortality at the Largest HIV Referral Center in Southern Vietnam.

Thao VP, Quang VM, Wolbers M, Anh ND, Shikuma C, Farrar J, Dunstan S, Chau NV, Day J, Thwaites G, Le T.

Medicine (Baltimore). 2015 Oct;94(43):e1715. doi: 10.1097/MD.0000000000001715. Erratum in: Medicine (Baltimore). 2016 Jan;95(1):1.

7.

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group.

AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709.

8.

Association of first-line and second-line antiretroviral therapy adherence.

Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC.

Open Forum Infect Dis. 2014 Sep 9;1(2):ofu079. doi: 10.1093/ofid/ofu079. eCollection 2014 Sep.

9.

Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.

Cardoso SW, Luz PM, Velasque L, Torres TS, Tavares IC, Ribeiro SR, Moreira RI, Veloso VG, Moore RD, Grinsztejn B.

BMC Infect Dis. 2014 Dec 19;14:699. doi: 10.1186/s12879-014-0699-5.

10.

Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.

Court R, Leisegang R, Stewart A, Sunpath H, Murphy R, Winternheimer P, Ally M, Maartens G.

BMC Infect Dis. 2014 Dec 4;14:664. doi: 10.1186/s12879-014-0664-3.

11.

Use of third line antiretroviral therapy in Latin America.

Cesar C, Shepherd BE, Jenkins CA, Ghidinelli M, Castro JL, Veloso VG, Cortes CP, Padgett D, Crabtree-Ramirez B, Gotuzzo E, Fink V, Duran A, Sued O, McGowan CC, Cahn P; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet).

PLoS One. 2014 Sep 15;9(9):e106887. doi: 10.1371/journal.pone.0106887. eCollection 2014.

12.

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia.

Chkhartishvili N, Sharvadze L, Dvali N, Karchava M, Rukhadze N, Lomtadze M, Chokoshvili O, Tsertsvadze T.

AIDS Res Ther. 2014 Jul 7;11:18. doi: 10.1186/1742-6405-11-18. eCollection 2014.

13.

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients.

Patel D, Desai M, Shah AN, Dikshit RK.

Perspect Clin Res. 2013 Oct;4(4):215-20. doi: 10.4103/2229-3485.120170.

14.

Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.

Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ.

PLoS One. 2013 Sep 17;8(9):e73582. doi: 10.1371/journal.pone.0073582. eCollection 2013.

15.

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.

Johnston V, Cohen K, Wiesner L, Morris L, Ledwaba J, Fielding KL, Charalambous S, Churchyard G, Phillips A, Grant AD.

J Infect Dis. 2014 Mar 1;209(5):711-20. doi: 10.1093/infdis/jit411. Epub 2013 Aug 13.

16.

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.

Schoffelen AF, Wensing AM, Tempelman HA, Geelen SP, Hoepelman AI, Barth RE.

PLoS One. 2013;8(3):e58526. doi: 10.1371/journal.pone.0058526. Epub 2013 Mar 11.

17.

Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies.

Wandeler G, Keiser O, Mulenga L, Hoffmann CJ, Wood R, Chaweza T, Brennan A, Prozesky H, Garone D, Giddy J, Chimbetete C, Boulle A, Egger M; IeDEA Southern Africa Collaboration.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):41-8.

18.

Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti.

Charles M, Leger PD, Severe P, Guiteau C, Apollon A, Gulick RM, Johnson WD Jr, Pape JW, Fitzgerald DW.

J Int AIDS Soc. 2012 Jun 14;15(2):17375. doi: 10.7448/IAS.15.2.17375.

19.

Second-line antiretroviral therapy: long-term outcomes in South Africa.

Murphy RA, Sunpath H, Castilla C, Ebrahim S, Court R, Nguyen H, Kuritzkes DR, Marconi VC, Nachega JB.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):158-63.

20.

Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.

Johnston V, Fielding K, Charalambous S, Mampho M, Churchyard G, Phillips A, Grant AD.

PLoS One. 2012;7(5):e36997. doi: 10.1371/journal.pone.0036997. Epub 2012 May 29.

Items per page

Supplemental Content

Write to the Help Desk